The authors concluded that mammalian central nervous system neurons possess the capacity for dendritic and synaptic regeneration following injury, proposing insulin and its analogs as promising therapeutic agents capable of inducing pro-regenerative responses in currently untreatable neurodegenerative diseases such as GL [30]. This evidence concerns the gene INS and neurodegenerative disease.